Northern Venture Trust plc (NVT) Ordinary 25p
Sell:55.50p
Buy:58.50p
0
Change:
No change
No change
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:55.50p
Buy:58.50p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:55.50p
Buy:58.50p
Change:
No change
No change
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
The Company’s objective is to provide long-term tax-free returns to investors through a combination of dividend yield and capital growth, by following its strategy of investing primarily in unquoted UK businesses which meet the Investment Adviser’s key criteria of good growth potential, strong management and potential to generate cash in the medium to long term.
| Security | Weight |
|---|---|
| Gentronix | 4.05% |
| Grip-Uk (T/A Climbing Hangar) | 3.64% |
| Volumatic Holdings | 2.85% |
| Tutora (T/A Tutorful) | 2.69% |
| Pure Pet Food | 2.55% |
| Project Glow Topco (T/A Currentbody.Com) | 2.47% |
| Newcells Biotech | 2.47% |
| Rockar | 2.33% |
| Biological Preparations Group | 2.27% |
| Netacea | 2.17% |
Top 10 sectors currently unavailable.
Top 10 countries currently unavailable.
Fee Structure
Management fee of 2.06% p.a. of NAV. Performance fee is 15% of the total return in excess of a hurdle rate. The agreement may be terminated by not less than 12months notice.
Dividend Policy
The Company will distribute most, if not all, of its available income each year by way of an interim dividend in June and a final dividend in December. Furthermore, the Directors intend that the investment portfolio will be managed with a view to generating capital gains for distribution.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Deborah HudsonChairman, David Mayes, Brigid Sutcliffe, John Milad
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.